Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
5(56%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
11%
Ph phase_3
1
11%
Ph phase_1
2
22%
Ph not_applicable
5
56%

Phase Distribution

2

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
2(22.2%)
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
1(11.1%)
N/ANon-phased studies
5(55.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

9

all time

Status Distribution
Active(6)
Completed(2)
Other(1)

Detailed Status

Recruiting4
Completed2
Active, not recruiting1
Enrolling by invitation1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
5
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (22.2%)
Phase 21 (11.1%)
Phase 31 (11.1%)
N/A5 (55.6%)

Trials by Status

active_not_recruiting111%
enrolling_by_invitation111%
recruiting444%
completed222%
unknown111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
9